EW logo

EW
Edwards Lifesciences Corp

4,915
Mkt Cap
$47.01B
Volume
806,092.00
52W High
$87.89
52W Low
$65.94
PE Ratio
33.51
EW Fundamentals
Price
$77.60
Prev Close
$78.71
Open
$78.86
50D MA
$84.25
Beta
0.73
Avg. Volume
3.68M
EPS (Annual)
$1.46
P/B
4.48
Rev/Employee
$344,272.15
Loading...
Loading...
News
all
press releases
Azzad Asset Management Inc. ADV Boosts Stake in Edwards Lifesciences Corporation $EW
Azzad Asset Management Inc. ADV lifted its position in shares of Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 330.5% during the 3rd quarter, according to its most recent disclosure...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
BI Asset Management Fondsmaeglerselskab A S Grows Position in Edwards Lifesciences Corporation $EW
BI Asset Management Fondsmaeglerselskab A S boosted its stake in shares of Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 76.1% during the third quarter, according to the company in its...
MarketBeat·1d ago
News Placeholder
Savant Capital LLC Has $3.24 Million Position in Edwards Lifesciences Corporation $EW
Savant Capital LLC increased its holdings in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 61.3% in the 3rd quarter, according to its most recent disclosure with the Securities...
MarketBeat·1d ago
News Placeholder
Edwards Lifesciences Corporation $EW Shares Sold by AE Wealth Management LLC
AE Wealth Management LLC lowered its stake in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 94.5% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·3d ago
News Placeholder
Edwards Lifesciences (EW) Shares Cross Below 200 DMA
In trading on Thursday, shares of Edwards Lifesciences Corp (Symbol: EW) crossed below their 200 day moving average of $79.43, changing hands as low as $78.98 per share. Edwards Lifesciences Corp...
Nasdaq News: Markets·4d ago
News Placeholder
Ahead of Edwards Lifesciences (EW) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Zacks·4d ago
News Placeholder
Edwards Lifesciences Corporation $EW Shares Sold by Machina Capital S.A.S.
Machina Capital S.A.S. decreased its position in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 54.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·4d ago
News Placeholder
Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect
EW gears up for Q4 earnings as investors watch TAVR momentum, fast-growing TMTT sales and steady surgical heart demand.
Zacks·5d ago
News Placeholder
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and will host a conference call at...
Business Wire·6d ago
News Placeholder
Retirement Systems of Alabama Acquires Shares of 125,240 Edwards Lifesciences Corporation $EW
Retirement Systems of Alabama bought a new stake in Edwards Lifesciences Corporation (NYSE:EW - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·11d ago
<
1
2
...
>

Latest EW News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.